Operating Income (Loss) in USD of Cabaletta Bio, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cabaletta Bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2018 to Q3 2025.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$46.6M, a 41% decline year-over-year.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$163M, a 42.7% decline year-over-year.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2024 was -$125M, a 67.6% decline from 2023.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2023 was -$74.7M, a 37.9% decline from 2022.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2022 was -$54.1M, a 16.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Cabaletta Bio, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$163M -$46.6M -$13.5M -41% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$150M -$45.9M -$15.6M -51.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$134M -$37.1M -$9.11M -32.5% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$125M -$33.8M -$10.6M -46% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$115M -$33M -$14.4M -77% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$100M -$30.3M -$14.4M -90.6% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$85.7M -$28M -$11.1M -65.3% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$74.7M -$23.1M -$6.84M -42% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$67.8M -$18.7M -$6.89M -58.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$60.9M -$15.9M -$2.83M -21.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$58.1M -$17M -$3.96M -30.4% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$54.1M -$16.3M -$2.41M -17.3% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$51.7M -$11.8M -$215K -1.86% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$51.5M -$13.1M -$1.92M -17.2% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$49.6M -$13M -$3.29M -33.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$46.3M -$13.9M -$4.56M -48.9% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$41.8M -$11.6M -$3.15M -37.4% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$38.6M -$11.1M -$2.95M -36% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$35.7M -$9.71M -$1.82M -23% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$33.8M -$9.33M -$3.47M -59.2% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$30.4M -$8.42M -$3.39M -67.3% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 -$27M -$8.19M -$4.39M -115% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$22.6M -$7.9M -$3.91M -97.9% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021
Q4 2019 -$18.7M -$5.86M 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 -$5.03M -$1.95M -63.3% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$3.8M 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$3.99M 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q3 2018 -$3.08M 01 Jul 2018 30 Sep 2018 10-Q 05 Dec 2019

Cabaletta Bio, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$125M -$50.5M -67.6% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$74.7M -$20.5M -37.9% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$54.1M -$7.83M -16.9% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$46.3M -$12.5M -36.9% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$33.8M -$15.2M -81.1% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$18.7M -$12.5M -202% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$6.19M 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.